Jennifer L. Atlas, MD

Articles

Basal Cell Carcinoma Clinical Pearls

July 18th 2022

Drs Babakoohi and Atlas share clinical pearls for community oncologists on treating basal cell carcinoma.

Metastasis Patterns of Basal Cell Carcinoma

July 18th 2022

A look at how common metastatic basal cell carcinoma is in clinical practice and when to consider frontline immunotherapy.

Safety of Cemiplimab for Basal Cell Carcinoma

July 7th 2022

Experts review the safety and toxicity data of anti-PD-1 antibody agent cemiplimab for basal cell carcinoma treatment.

Clinical Scenario 2: A 66-Year-Old Woman with Locally Advanced Basal Cell Carcinoma

July 7th 2022

Jennifer Atlas, MD, presents the case of a 66-year-old woman with locally advanced basal cell carcinoma not responding to frontline treatment.

Monitoring Strategies for Basal Cell Carcinoma

July 6th 2022

Shahab Babakoohi, MD, describes his monitoring strategies for patients with basal cell carcinoma.

Systemic Therapy Options for Basal Cell Carcinoma

July 1st 2022

Dr Jennifer Atlas leads a conversation on systemic therapy options in basal cell carcinoma with a review of clinical trial data.

Treatment Options for Locally Advanced Basal Cell Carcinoma

June 23rd 2022

Experts review the currently available treatment options for locally advanced basal cell carcinoma.

Referring Patients with Basal Cell Carcinoma to Medical Oncology

June 23rd 2022

Dr. Shahab Babakoohi explains when to refer a patient with basal cell carcinoma from a dermatology practice to a medical oncologist.

Clinical Scenario 1: A 74-Year-Old Man with Locally Advanced Infiltrative Basal Cell Carcinoma

June 15th 2022

Jennifer Atlas, MD, presents the clinical scenario of a man with locally advanced basal cell carcinoma.

Overview of Basal Cell Carcinoma

June 15th 2022

Shahab Babakoohi, MD, describes the incidence patterns, options for testing and diagnosis, and risk stratification for basal cell carcinoma.

Dr. Atlas on the Promise of Up-Front Cemiplimab in Locally Advanced CSCC

August 19th 2020

Jennifer L. Atlas, MD, discusses the promise of cemiplimab in the treatment of patients with locally advanced cutaneous squamous cell carcinoma.

Dr. Atlas on the Current Treatment Paradigm in CSCC

August 14th 2020

Jennifer L. Atlas, MD, discusses the ​current cutaneous squamous cell carcinoma treatment paradigm.

Dr. Atlas on the Rationale for Cemiplimab in Locally Advanced CSCC

August 7th 2020

Jennifer L. Atlas, MD, discusses the rationale for using cemiplimab-rwlc as a first intervention for patients with locally advanced cutaneous squamous cell carcinoma.